World's Best Scientists 2026 revealed!
Hanns-Ulrich Marschall

Hanns-Ulrich Marschall

D-Index & Metrics

Medicine

D-Index
87
Citations
34479
World Ranking
13490
National Ranking
254

Overview

Hanns-Ulrich Marschall is affiliated with the University of Gothenburg in Sweden. Their research primarily focuses on medicine, with particular attention to epidemiology, hepatology, surgery, oncology, and molecular biology.

The scientist's principal areas of study include:

  • Liver Disease Diagnosis and Treatment
  • Drug Transport and Resistance Mechanisms
  • Liver Diseases and Immunity
  • Pediatric Hepatobiliary Diseases and Treatments
  • Endoplasmic Reticulum Stress and Disease
  • Liver Disease and Transplantation
  • Gut microbiota and health

Marschall has contributed extensively to academic literature with a notable presence in several publication venues. Frequent venues for their work include:

  • Journal of Hepatology
  • JHEP Reports
  • Liver International
  • Hepatology Communications
  • Nature Communications

Their recent papers demonstrate a focus on liver-related diseases and metabolic functions, including titles such as:

  • FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption (2021, Cell Metabolism)
  • Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment (2022, Nature Communications)
  • Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis (2021, The Lancet. Gastroenterology & Hepatology)
  • 6α-hydroxylated bile acids mediate TGR5 signalling to improve glucose metabolism upon dietary fiber supplementation in mice (2022, Gut)
  • Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling (2021, Nature Metabolism)

Collaborations play a significant role in Marschall's research output. Frequent co-authors include:

  • Catherine Williamson
  • Christian Trautwein
  • Annika Wahlström
  • Jan G. Hengstler
  • Karolina Edlund

Best Publications

  • Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.

    Annika Wahlström;Sama I. Sayin;Hanns-Ulrich Marschall;Fredrik Bäckhed;Fredrik Bäckhed

  • Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist.

    Sama I. Sayin;Annika Wahlström;Jenny Felin;Sirkku Jäntti

  • Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.

    Ringdén O;Uzunel M;Rasmusson I;Remberger M

  • Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.

    Anna Glantz;Hanns Ulrich Marschall;Lars Åke Mattsson

  • A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

    F. Nevens;P. Andreone;G. Mazzella;S. I. Strasser

  • Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.

    Sunder Mudaliar;Robert R. Henry;Arun J. Sanyal;Linda Morrow

  • Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management.

    Frank Lammert;Hanns-Ulrich Marschall;Anna Glantz;Siegfried Matern

  • Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid

    Gideon M. Hirschfield;Andrew Mason;Velimir Luketic;Velimir Luketic;Keith Lindor;Keith Lindor

  • Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota

    Jun Wang;Louise B Thingholm;Jurgita Skiecevičienė;Philipp Rausch;Philipp Rausch

  • Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

    Peter Fickert;Andrea Fuchsbichler;Martin Wagner;Gernot Zollner

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • High-dose ursodeoxycholic acid in primary sclerosing cholangitis : a 5-year multicenter, randomized, controlled study.

    Rolf Olsson;Kirsten M Boberg;Ove Schaffalitsky de Muckadell;Stefan Lindgren

  • The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

    Martin Kummen;Kristian Holm;Jarl Andreas Anmarkrud;Ståle Nygård;Ståle Nygård

  • Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.

    Caroline Ovadia;Paul T Seed;Alexandros Sklavounos;Victoria Geenes

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations.

    Gernot Zollner;Hanns-Ulrich Marschall;Martin Wagner;Michael Trauner

  • An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans

    Adil Mardinoglu;Hao Wu;Elias Bjornson;Cheng Zhang

  • Whole-genome sequencing of patients with rare diseases in a national health system

    Ernest Turro;William J Astle;Karyn Megy;Stefan Graf

  • CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice

    Martin Wagner;Emina Halilbasic;Hanns-Ulrich Marschall;Gernot Zollner

  • A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.

    Peter Fickert;Ulrike Stöger;Andrea Fuchsbichler;Tarek Moustafa

Frequent Co-Authors

Michael Trauner
Michael Trauner Medical University of Vienna
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Kurt Zatloukal
Kurt Zatloukal Medical University of Graz
Jonas F. Ludvigsson
Jonas F. Ludvigsson Karolinska Institute
Tom H. Karlsen
Tom H. Karlsen Oslo University Hospital
Kirsten Muri Boberg
Kirsten Muri Boberg University of Oslo
Roger W. Chapman
Roger W. Chapman University of Oxford
Helmut Denk
Helmut Denk Medical University of Graz
Fredrik Bäckhed
Fredrik Bäckhed University of Gothenburg
Jan Borén
Jan Borén University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, exploring online education options can be a great way to advance your healthcare career while balancing personal commitments. There are several flexible online programs tailored for different stages in a medical or healthcare journey.

For those beginning their careers, nursing school online offers a convenient and often affordable pathway to enter the nursing profession. If you’re already a registered nurse, cheap rn to bsn programs allow you to earn your Bachelor of Science in Nursing quickly and cost-effectively.

For non-nurses seeking to transition into the field, direct entry msn programs for non-nurses online can help you earn a master’s degree and qualify for advanced roles. Aspiring nurse leaders and educators can pursue online phd nursing programs to deepen their expertise and open doors to high-level positions in academics or research.

Each of these online degrees supports a variety of career pathways in healthcare, making it easier than ever to achieve your professional goals in medicine and allied fields.

Best Scientists Citing Hanns-Ulrich Marschall

Trending Scientists

Recently Published Articles